{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-093021","form_type":"8-K","ticker":"ORKA","cik":"0000907654","company_name":"Oruka Therapeutics, Inc.","filed_at":"2026-08-24T20:06:13+00:00","discovered_at":"2026-08-24T20:07:00.516071+00:00","generated_at":"2026-08-24T20:07:14.791483+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oruka names Todd Edwards Chief Commercial Officer, eff. Aug 24 2026","bullets":["Todd Edwards, ex-CCO of Arcutis Biotech, starts as Oruka's Chief Commercial Officer on Aug 24, 2026, reporting to CEO.","Annual base salary $525,000; target bonus 40% of base; $200,000 signing bonus repayable prorated if resignation within 1 year.","Equity grant: 20,000 options + 100,000 RSUs; options vest 25% at 1yr then monthly over 36mo, RSUs quarterly.","Severance: 12 months base salary outside CIC; within CIC 1.0x (base+target) plus full acceleration of time-based equity."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-093021","json":"https://secwatch.observer/filing/0001213900-26-093021.json","markdown":"https://secwatch.observer/filing/0001213900-26-093021.md","text":"https://secwatch.observer/filing/0001213900-26-093021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/907654/000121390026093021/0001213900-26-093021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/907654/000121390026093021/ea0302923-8k_oruka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-24T20:07:14.791483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}